Status:
TERMINATED
Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome
Lead Sponsor:
Lahey Clinic
Collaborating Sponsors:
Beth Israel Deaconess Medical Center
Dr. Vikas Sukhatme
Conditions:
Hepatorenal Syndrome
Renal Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This Study will look at the effect of substances called "angiogenic factors"(development of new blood vessels) have on the development of severe liver disease. The results may help to understand the f...
Detailed Description
Renal dysfunction in patients who also suffer from end stage liver disease is associated with increased morbidity and mortality comparted to patients suffering from liver disease alone. If frank renal...
Eligibility Criteria
Inclusion
- Sign informed consent
- Subjects who present for Liver Transplantation
- Subjects who present for Hepatic resection
- Subjects with Non-Surgical Liver Disease
Exclusion
- Absence of Liver Disease
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00734136
Start Date
May 1 2005
End Date
February 1 2009
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lahey Clinic, Inc.
Burlington, Massachusetts, United States, 01805